Latest Breaking News On - Counter vaccine hesitancy - Page 1 : comparemela.com

/PRNewswire/ Novavax, Inc. (Nasdaq: NVAX), a global company advancing protein-based vaccines with its novel Matrix-M™ adjuvant, will present data on its.

United statesErika schultzAli chartanNovavax incVaccine technology platform awardPrnewswire novavax incWorld vaccine congressEuropean congressInfluenza combinationClinical microbiologyInfectious diseasesCounter vaccine hesitancyNew vaccinesBest new vaccinePlatform awardOvie awards